Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) fell 4.5% on Tuesday . The company traded as low as $22.99 and last traded at $23.05. 266,559 shares traded hands during trading, a decline of 58% from the average session volume of 630,100 shares. The stock had previously closed at $24.13. Wall Street Analysts Forecast Growth […]
HC Wainwright Reaffirms Buy Rating for Cullinan Therapeutics (NASDAQ:CGEM) wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.